| Antiviral | EC50 ratio | Phenotype | Strain | Source | Marker | Assay | Reference |
|---|---|---|---|---|---|---|---|
| Cidofovir | 1.90 | No resistance | Clinical Isolate | Details | Drug Resistance Mutations and Associated Phenotypes Detected in Clinical Trials of Maribavir for Treatment of Cytomegalovirus Infection. (Sep 2022) | ||
| Foscarnet | 5.70 | High level resistance | Clinical Isolate | Details | Drug Resistance Mutations and Associated Phenotypes Detected in Clinical Trials of Maribavir for Treatment of Cytomegalovirus Infection. (Sep 2022) | ||
| Ganciclovir | 3.20 | Intermediate level resistance | Clinical Isolate | Details | Drug Resistance Mutations and Associated Phenotypes Detected in Clinical Trials of Maribavir for Treatment of Cytomegalovirus Infection. (Sep 2022) |
| Mutant | Resistances |
|---|---|
| E989Q |
|